|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ann Thorac Surg 2007;83:S835-S841
© 2007 The Society of Thoracic Surgeons
Division of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota
* Address correspondence to Dr Sundt, Division of Cardiovascular Surgery, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Email: sundt.thoralf{at}mayo.edu).
Presented at Aortic Surgery Symposium X, New York, NY, April 2728, 2006.
Intramural hematoma and penetrating aortic ulcer are uncommon but potentially lethal thoracic aortic pathologies. Despite incomplete understanding of their natural history, they have emerged as anatomically appealing targets of endovascular therapy. Appropriate application of these technologies, however, must be predicated on an understanding of the fate of these lesions left untreated, and predictors of their misbehavior. We briefly review the current understanding of these entities.
This article has been cited by other articles:
![]() |
R. Gottardi, D. Zimpfer, M. Funovics, M. Schoder, J. Lammer, E. Wolner, M. Czerny, and M. Grimm Mid-term results after endovascular stent-graft placement due to penetrating atherosclerotic ulcers of the thoracic aorta Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1019 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Swee and M. D. Dake Endovascular Management of Thoracic Dissections Circulation, March 18, 2008; 117(11): 1460 - 1473. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |